Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Columbia Care Inc.
  6. Summary
    CCHW   CA1973091079

COLUMBIA CARE INC.

(CCHW)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  03:59:58 2023-01-27 pm EST
0.8500 CAD    0.00%
01/19Columbia Care Implements Efficiency Initiatives to Enhance Profitability
BU
2022Columbia Care Releases First Corporate Social Responsibility Report
BU
2022Columbia Care Opens Sixth Dispensary in Virginia
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
01/23/2023 01/24/2023 01/25/2023 01/26/2023 01/27/2023 Date
0.94(c) 0.9(c) 0.9(c) 0.835(c) 0.85(c) Last
235 131 295 289 170 247 61 903 204 301 Volume
-5.05% -4.26% 0.00% -7.22% +1.80% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 520 M - -
Net income 2022 -150 M - -
Net Debt 2022 519 M - -
P/E ratio 2022 -1,77x
Yield 2022 -
Sales 2023 623 M - -
Net income 2023 -86,4 M - -
Net Debt 2023 534 M - -
P/E ratio 2023 -3,85x
Yield 2023 -
Capitalization 263 M 263 M -
EV / Sales 2022 1,50x
EV / Sales 2023 1,28x
Nbr of Employees 2 586
Free-Float 21,6%
More Financials
Company
Columbia Care Inc. is a cultivator, manufacturer and provider of cannabis products and related services. The CompanyÔÇÖs principal business activity is the production and sale of cannabis. The Company operates approximately 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities. The Company offers products such as spanning flower, edibles, oils, and tablets. It manufactures brands... 
More about the company
Ratings of Columbia Care Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about COLUMBIA CARE INC.
01/19Columbia Care Implements Efficiency Initiatives to Enhance Profitability
BU
2022Columbia Care Releases First Corporate Social Responsibility Report
BU
2022Columbia Care Opens Sixth Dispensary in Virginia
BU
2022Columbia Care Inc. Opens Sixth Dispensary in Virginia
CI
2022Transcript : Columbia Care Inc., Q3 2022 Earnings Call, Nov 14, 2022
CI
2022COLUMBIA CARE INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
2022Columbia Care Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
2022Columbia Care Reports Third Quarter 2022 Results
BU
2022Columbia Care Continues Footprint Expansion in Virginia with New Dispensary Opening in ..
BU
2022Columbia Care Inc. Opens Cannabist Carytown on 3100 W Cary Street in Richmond
CI
2022Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois,..
CI
2022Columbia Care to Report Third Quarter 2022 Results on November 14, 2022
BU
2022áColumbia Care Introduces Hedy, a New Cannabis-Infused Edibles Brand
BU
2022Columbia Care Inc. Introduces Hedy, a New Cannabis-Infused Edibles Brand
CI
2022Columbia Care Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More news
News in other languages on COLUMBIA CARE INC.
2022Columbia Care Inc. ouvre un sixième dispensaire en Virginie
2022Columbia Care Inc. publie ses résultats pour le troisième trimestre et les neuf mois cl..
2022Columbia Care Inc. ouvre le cannabiste Carytown au 3100 W Cary Street à Richmond
2022Columbia Care Inc. présente Hedy, une nouvelle marque d'additifs infusés au cannabis
2022La marque Triple Seven de Columbia Care Inc. arrive sur un dixième marché
More news
Analyst Recommendations on COLUMBIA CARE INC.
More recommendations
Chart COLUMBIA CARE INC.
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 0,64 $
Average target price 4,21 $
Spread / Average Target 559%
EPS Revisions
Managers and Directors
Nicholas Keane Vita Chief Executive Officer & Director
Derek Watson Chief Financial Officer
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors